Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai By: CNBC.com News July 26, 2024 at 08:42 AM EDT The committee said Leqembi's effect on delaying cognitive decline does not outweigh "the risk of serious side effects associated with the medicine." Read More >> Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai By: CNBC.com News July 26, 2024 at 08:42 AM EDT The committee said Leqembi's effect on delaying cognitive decline does not outweigh "the risk of serious side effects associated with the medicine." Read More >>